Nasreen Khan

759 total citations
47 papers, 519 citations indexed

About

Nasreen Khan is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nasreen Khan has authored 47 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nasreen Khan's work include Multiple Sclerosis Research Studies (8 papers), Prostate Cancer Treatment and Research (8 papers) and Healthcare Policy and Management (7 papers). Nasreen Khan is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Prostate Cancer Treatment and Research (8 papers) and Healthcare Policy and Management (7 papers). Nasreen Khan collaborates with scholars based in United States, Switzerland and United Kingdom. Nasreen Khan's co-authors include Jack Zwanziger, Robert Kaestner, Harold J. Manley, Amy Barton Pai, Jonathan R. Korn, Jennie Medin, Robert Zivadinov, Dennis W. Raisch, Bianca Weinstock‐Guttman and Michael G. Dwyer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Nasreen Khan

40 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nasreen Khan United States	15	122	106	86	85	81	47	519
K Weiss United States	9	78 0.6×	19 0.2×	90 1.0×	84 1.0×	208 2.6×	14	661
Sara Wang United States	11	102 0.8×	137 1.3×	18 0.2×	147 1.7×	58 0.7×	17	613
Amie T. Joyce United States	15	139 1.1×	56 0.5×	46 0.5×	27 0.3×	73 0.9×	17	512
Yunji Hwang South Korea	17	32 0.3×	40 0.4×	40 0.5×	41 0.5×	74 0.9×	30	825
Jonathan R. Korn United States	17	81 0.7×	334 3.2×	18 0.2×	34 0.4×	47 0.6×	37	855
Shiraz R. Gupta United States	15	237 1.9×	123 1.2×	44 0.5×	52 0.6×	7 0.1×	20	1.2k
Michael Grabner United States	17	92 0.8×	11 0.1×	26 0.3×	68 0.8×	61 0.8×	80	811
Victoria Higgins United Kingdom	13	29 0.2×	39 0.4×	12 0.1×	50 0.6×	38 0.5×	36	992
Nilesh J. Samani United Kingdom	10	48 0.4×	13 0.1×	31 0.4×	58 0.7×	103 1.3×	11	772
Dejana Braithwaite United States	14	48 0.4×	34 0.3×	51 0.6×	51 0.6×	7 0.1×	63	741

Countries citing papers authored by Nasreen Khan

Since Specialization

Citations

This map shows the geographic impact of Nasreen Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasreen Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasreen Khan more than expected).

Fields of papers citing papers by Nasreen Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasreen Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasreen Khan. The network helps show where Nasreen Khan may publish in the future.

Co-authorship network of co-authors of Nasreen Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Nasreen Khan. A scholar is included among the top collaborators of Nasreen Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasreen Khan. Nasreen Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khan, Nasreen, et al.. (2025). Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer in Japan: The ARASHI Study. International Journal of Urology. 32(12). 1853–1861.

McKay, Rana R., Amee Morgans, Nasreen Khan, et al.. (2025). Clinical use and outcomes of androgen-receptor pathway inhibitors triplet therapy for metastatic hormone-sensitive prostate cancer (ARAAT).. Journal of Clinical Oncology. 43(5_suppl). 66–66.

George, Daniel J., Alicia K. Morgans, Nasreen Khan, et al.. (2024). US real-world utilization and outcomes of darolutamide, enzalutamide, and apalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC): DEAR-EXT study.. JCO Oncology Practice. 20(10_suppl). 399–399. 1 indexed citations

George, Daniel J., et al.. (2024). Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer. JAMA Network Open. 7(8). e2429783–e2429783. 4 indexed citations

Morgans, Alicia K., Neal D. Shore, Nasreen Khan, et al.. (2023). Comparative real-world (RW) evidence on darolutamide (Daro), enzalutamide (Enza), and apalutamide (Apa) for patients (Pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in the United States: DEAR.. Journal of Clinical Oncology. 41(16_suppl). 5097–5097. 2 indexed citations

Khan, Nasreen, Raquel Cabo, Rebecca D. Burdine, et al.. (2023). Health-related quality of life and medication use among individuals with Angelman syndrome. Quality of Life Research. 32(7). 2059–2067. 3 indexed citations

Khan, Nasreen, et al.. (2022). Identification of suitable habitat for Taxus wallichiana and Abies pindrow in moist temperate forest using maxent modelling technique. Saudi Journal of Biological Sciences. 29(12). 103459–103459. 19 indexed citations

Khan, Nasreen, et al.. (2019). An observational study of pediatric healthcare burden in Angelman syndrome: results from a real-world study. Orphanet Journal of Rare Diseases. 14(1). 239–239. 8 indexed citations

Zivadinov, Robert, Jennie Medin, Nasreen Khan, et al.. (2018). Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study. Multiple Sclerosis and Related Disorders. 27. 65–73. 5 indexed citations

10.

Dwyer, Michael G., Jesper Hagemeier, Niels Bergsland, et al.. (2018). Establishing pathological cut-offs for lateral ventricular volume expansion rates. NeuroImage Clinical. 18. 494–501. 25 indexed citations

11.

Khan, Nasreen, et al.. (2017). Profiling of secondary metabolites and antimicrobial activity of Crateva religiosa G. Forst. Bark – A rare medicinal plant of Maharashtra India. International Journal of Biosciences (IJB). 10(5). 343–354. 5 indexed citations

12.

Zivadinov, Robert, Niels Bergsland, Jonathan R. Korn, et al.. (2017). Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS. American Journal of Neuroradiology. 39(2). 289–295. 24 indexed citations

13.

Khan, Akram, et al.. (2017). Association of massive transfusion for resuscitation in gastrointestinal bleeding with transfusion-related acute lung injury. Indian Journal of Critical Care Medicine. 21(8). 506–513. 4 indexed citations

14.

Briggs, Andrew, Patrick S. Parfrey, Nasreen Khan, et al.. (2016). Analyzing Health-Related Quality of Life in the EVOLVE Trial. Medical Decision Making. 36(8). 965–972. 20 indexed citations

15.

Khan, Nasreen, et al.. (2013). Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes. Diabetes Research and Clinical Practice. 102(3). 233–241. 3 indexed citations

16.

Khan, Nasreen. (2010). Does Supply Influence Mammography Screening. American Journal of Health Behavior. 34(4). 465–75. 7 indexed citations

17.

Zwanziger, Jack, Nasreen Khan, & Anil Bamezai. (2010). The relationship between safety net activities and hospital financial performance. BMC Health Services Research. 10(1). 15–15. 22 indexed citations

18.

Khan, Nasreen, et al.. (2010). Relationship between diet, exercise habits, and health status among patients with diabetes. Research in Social and Administrative Pharmacy. 7(2). 151–161. 17 indexed citations

19.

Khan, Nasreen & Robert Kaestner. (2009). Effect of Prescription Drug Coverage on the Elderly's Use of Prescription Drugs. INQUIRY The Journal of Health Care Organization Provision and Financing. 46(1). 33–45. 14 indexed citations

20.

Pai, Amy Barton, et al.. (2009). Reduced Drug Use and Hospitalization Rates in Patients Undergoing Hemodialysis Who Received Pharmaceutical Care: A 2‐Year, Randomized, Controlled Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(12). 1433–1440. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact